Trials / Completed
CompletedNCT06037668
A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.
BVR-100 and BES-100 Validation Trial: A Randomized, Double-Blind, Parallel-Group, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Sumitomo Pharma America, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study is to compare two Virtual Reality (VR)-based interventions, BVR-100 and BES-100, for the treatment of Social Anxiety Disorder (SAD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BVR-100 | Experimental self-guided VR intervention for the treatment of SAD |
| DEVICE | BES-100 | Active at-home VR intervention comparator |
Timeline
- Start date
- 2023-09-08
- Primary completion
- 2023-12-22
- Completion
- 2024-01-10
- First posted
- 2023-09-14
- Last updated
- 2025-03-12
- Results posted
- 2025-03-12
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06037668. Inclusion in this directory is not an endorsement.